Filing Details

Accession Number:
0001534969-22-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-04 18:15:12
Reporting Period:
2022-05-04
Accepted Time:
2022-05-04 18:15:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534969 Sera Prognostics Inc. SERA Services-Medical Laboratories (8071) 261911522
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870674 J. John Boniface C/O Sera Prognostics, Inc.
2749 East Parleys Way, Suite 200
Salt Lake City UT 84109
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-05-04 1,000 $0.73 80,210 No 4 M Direct
Class A Common Stock Disposition 2022-05-04 1,000 $2.17 79,210 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Disposition 2022-05-04 1,000 $0.00 1,000 $0.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,844 2022-09-11 No 4 M Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.11 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. The shares subject to this option are fully vested and exercisable.